Unos 200 pacientes serán parte del programa de ablación cardíaca pediátrica, que este fin de semana se inició con la primera jornada de estudio electrofisiológico y ablación de arritmias que benefició ...

It was quite a red flag. Alla Feldbeyn was stunned by unexpected vaginal bleeding in November 2020, many years after she had gone through menopause. The Florida grandmother of four was diagnosed with ...

Rina-S has received FDA breakthrough therapy designation for advanced endometrial cancer after standard treatments fail, based on promising Phase 1/2 trial results. The RAINFOL-01 trial showed ...

El proyecto de ley "Niñas sin ablación" pasó su segundo trámite legislativo en abril de 2025. Tanto congresistas como mujeres indígenas de la comunidad emberá han participado en el ...

The National Institute for Health and Care Excellence (NICE) has recommended a combination treatment for advanced endometrial cancer, calling it a “major step forward.” This is the first time ...

Robotic surgery is a high-tech tool, not an autonomous surgeon; a human is always in control. Key benefits include smaller cuts, less bleeding, and a quicker recovery compared to open surgery. The ...

Increased endometrial thickness is a potential sign of endometrial cancer. Doctors are most likely to be concerned if you also experience bleeding. Endometrial thickness refers to the thickness of the ...

The projections come as data shows increases in uterine cancer cases and deaths. Uterine cancer cases in the U.S. will rise significantly by 2050, with Black women three times more likely to die from ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

Vienna, Austria – Endometrial cancer is the most common gynecological cancer in high-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early ...

Endometrial cancer is treatable and, if found in time, has a good five-year outcome for patients. However, once it spreads outside the uterus, it becomes difficult to effectively treat – which makes ...